18 July 2025
Cancers | Highly Cited Special Issues in 2024 in the “Cancer Immunology and Immunotherapy” Section
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some highly cited Special Issues in 2024 from the “Cancer Immunology and Immunotherapy” Section of Cancers (ISSN: 2072-6694).
The list of highly cited Special Issues can be viewed below:
“Inflammation, Immunity, and Cancer Progression”
Guest Editors: Dr. Deepak Parashar, Dr. Vivek K. Kashyap and Dr. Subhash Tripathi
Submission deadline: 31 May 2024
“PD-1/PD-L1 Immune Checkpoint Therapy: From Predictive Biomarkers to Noninvasive Imaging”
Guest Editors: Prof. Dr. Patrizia Ferroni, Prof. Dr. Fiorella Guadagni and Prof. Dr. Mario Roselli
Submission deadline: 25 April 2024
“Role of Immune Checkpoint Inhibitors or Targeted Therapy in the Treatment of Patients with Melanoma Volume II”
Guest Editors: Dr. Henrik Schmidt and Dr. Eva Ellebæk
Submission deadline: 20 September 2024
“Near-Infrared Photoimmunotherapy for Cancer Treatment”
Guest Editor: Dr. Hisataka Kobayashi
Submission deadline: 10 April 2024
“Macrophage-Directed Cancer Immunotherapy”
Guest Editor: Dr. Zahra Payandeh
Submission deadline: 31 December 2024
“State-of-the-Art Cancer Immunology and Immunotherapy in the USA”
Guest Editors: Prof. Dr. Razelle Kurzrock, Dr. Anwaar Saeed, Dr. Linlin Guo and Dr. Ludimila Cavalcante
Submission deadline: 20 June 2024
We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office